Metraipolis › archive › dc_019787edc4aa

Evaluating plasma carboxylesterase 1 as a protein biomarker for pharmacokinetics and metabolic dysfunction-associated steatotic liver disease — Europe PMC PMID:42250372

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42250372
DOI
10.1016/j.dmd.2026.100307
License (as archived)
solo-consultazione
Archived
2026-11-03T00:00:39.876Z
SHA-256 of the archived text
d2d26fca1d7c258143e235ed9279fad66e3b40902100b3925d447687129f9aa0
Stable URL of this page
https://metraipolis.com/documento/dc_019787edc4aa

How to cite

Evaluating plasma carboxylesterase 1 as a protein biomarker for pharmacokinetics and metabolic dysfunction-associated steatotic liver disease — Europe PMC PMID:42250372 — Europe PMC (en), https://europepmc.org/article/MED/42250372 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_019787edc4aa (Metraipolis archive dc_019787edc4aa, sha256 d2d26fca1d7c258143e235ed9279fad66e3b40902100b3925d447687129f9aa0)
BibTeX
@misc{dc019787edc4aa,
  title = {Evaluating plasma carboxylesterase 1 as a protein biomarker for pharmacokinetics and metabolic dysfunction-associated steatotic liver disease — Europe PMC PMID:42250372},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42250372},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_019787edc4aa; sha256 d2d26fca1d7c258143e235ed9279fad66e3b40902100b3925d447687129f9aa0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42250372. Agents can read the archived copy with the MCP tool read_document.